首页 › 基金 › Rhenman & Partners Asset Management AB › CRL
Rhenman & Partners Asset Management AB 对 CRL 的持仓历史
CHARLES RIV LABS INTL INC · 医疗保健
Rhenman & Partners Asset Management AB 在 Q3 2026 的 13F 申报中披露持有 CRL(CHARLES RIV LABS INTL INC)46,800 股,市值约 US$13.8M,约占其申报组合的 1.53%,在其申报持仓中市值排名第 23 位。 Rhenman & Partners Asset Management AB 最近 13 个申报季度中有 10 个季度披露了 CRL 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Rhenman & Partners Asset Management AB 对 CRL 的持仓演变
Rhenman & Partners Asset Management AB 于 Q3 2023 首次披露 CRL 持仓:44,000 股(约 US$8.6M)。 该持仓在 Q3 2026 达到峰值 46,800 股,市值约 US$13.8M。 在 10 次申报中,Rhenman & Partners Asset Management AB 4 次增持、4 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 46,800 股、市值约 US$13.8M,环比减持 -10,400 股。。 持仓曾出现大幅变动:Q1 2024 减持约 67% (随后一个季度股价下跌 24%)、Q2 2024 增持约 168% (随后一个季度股价下跌 5%)、Q2 2026 增持约 120% (随后一个季度股价上涨 30%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 44.00K | $8.62M | 新进 |
| Q4 2023 | 38.00K | $8.98M | 减持 |
| Q1 2024 | 12.70K | $3.44M | 减持 |
| Q2 2024 | 34.00K | $7.02M | 增持 |
| Q3 2024 | 37.50K | $7.39M | 增持 |
| Q4 2024 | 14.85K | $2.74M | 减持 |
| Q4 2025 | 22.00K | $4.39M | 新进 |
| Q1 2026 | 26.00K | $4.49M | 增持 |
| Q2 2026 | 57.20K | $12.97M | 增持 |
| Q3 2026 | 46.80K | $13.81M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CRL 与 13F 数据
CRL(CHARLES RIV LABS INTL INC)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 CRL,申报仓位最大的包括:ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CRL 的基金
- ARIEL INVESTMENTS, LLC 1.19M 股 · $352.05M · Q3 2026
- EARNEST PARTNERS LLC 1.09M 股 · $320.67M · Q3 2026
- Allspring Global Investments Holdings, LLC 887.52K 股 · $254.57M · Q3 2026
- COOKE & BIELER LP 432.12K 股 · $127.48M · Q3 2026
更多关于 Rhenman & Partners Asset Management AB
常见问题
How long has Rhenman & Partners Asset Management AB held CRL?
Rhenman & Partners Asset Management AB has disclosed CRL holdings in 10 of the last 13 reported quarters, going back to Q3 2023.
What is Rhenman & Partners Asset Management AB's current position in CRL?
As of Q3 2026, Rhenman & Partners Asset Management AB holds 46.80K shares of CRL (CHARLES RIV LABS INTL INC), valued at $13.81M, representing 1.53% of its reported portfolio and ranking #23.
Has Rhenman & Partners Asset Management AB been buying or selling CRL?
In the latest 13F filing (Q3 2026), Rhenman & Partners Asset Management AB reduced its position in CRL. The position peaked in Q3 2026 at 46.80K shares.
Which other funds hold CRL?
Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.